The Public Health Commission has decided to maintain the duration of quarantines with COVID infection, currently set at 7 days, although there were several proposals from different autonomous regions to reduce them to a period of between 3 and 5 days.
In addition, the document of recommendations for selecting candidates to receive the drug approved by the European Medicines Agency, Evusheld, for the prevention of the coronavirus, was approved. In a measure agreed by consensus among the autonomous regions, people aged 18 years or older with severe immunosuppression who do not respond to vaccination and those at high risk of severe disease following coronavirus infection will be tested.
The update of the vaccination strategy in Spain has been approved adding the latest decisions of the Public Health Commission on the period to be spent for vaccination after infection has passed.
The application of the Novavax vaccine and booster doses in people with high-risk conditions and on immunosuppressive treatments has also been agreed. The Novavax vaccine is recommended for people who have not been able to be vaccinated or who have received incomplete vaccination due to allergies or incompatibility with any of the components of other vaccines.